Meet Our Distinguished Academic Advisory Board

oncology-analytics-dr-eisenbergerDeborah Dillon, MD
Advisory Board Member
Dr. Deborah Dillon is Assistant Professor of Pathology at Harvard Medical School. She received her MD at Yale Medical School and is board-certified in Anatomic and Molecular Genetic Pathology. She has worked as a breast and molecular pathologist for 20 years and has been on staff at Brigham and Women’s Hospital in Boston since 2004. As part of her clinical work in molecular diagnostics, she interprets both single-gene assays as well as high-throughput sequencing for solid tumors. In addition to clinical work in breast pathology and molecular diagnostics, Dr. Dillon’s particular area of interest is in biomarker development.
Dr. Dillon is a member of the College of American Pathologists Steering Committee for Biomarker Reporting and is a co-author of the CAP Templates for Reporting Results of Biomarker Testing in Breast Cancer and for Biomarker Reporting in Tumors of the Central Nervous System. She collaborates with basic scientists in the evaluation of new markers for breast cancer and new techniques for molecular analysis and works closely with breast oncologists in biomarker evaluation for clinical trials. She also serves as Director of the Dana Farber Harvard Cancer Center Breast Tissue Bank and Translational Research Laboratory and is a member of the pathology committee for the Alliance for Clinical Trials in Oncology.
oncology-analytics-dr-eisenbergerMario Eisenberger, MD
Advisory Board Member
Dr. Eisenberger began his career in private practice as a medical oncologist and hematologist in 1978. He subsequently served as senior investigator for the Cancer Therapy Evaluation Program of the National Cancer Institute and Chief of Oncology at the Baltimore Veteran’s Administration Hospital.
Also, he has held faculty appointments in oncology and urology at the University of Miami and the University of Maryland. Dr. Eisenberger joined the faculty of Johns Hopkins as an associate professor of Urology and Oncology in 1993, and became a professor in both specialties in 1998. He is a member of the American Association of Cancer Research, the National Prostate Cancer Education Council, and the International Task Force of the American Society of Clinical Oncology. Dr. Eisenberger has published more than 200 articles and 40 book chapters. In addition, in 2004, he received a clinical investigator award from the Prostate Cancer Foundation.
oncology-analytics-dr-epsteinJonathan I. Epstein, MD
Advisory Board Member
Dr. Epstein was in the Phi Beta Kappa Society and graduated Summa Cum Laude from college at Boston University. Also, he was in the Alpha Omega Alpha Society at Boston University Medical School. Next, Dr. Epstein completed a pathology residency at Johns Hopkins Hospital and a pathology fellowship at Memorial Sloan-Kettering Cancer Center.
Currently, he is a professor in the Departments of Pathology, Urology and Oncology at Johns Hopkins Hospital. He has written more than 800 articles, 50 book chapters and 14 books. Dr. Epstein is an international expert and thought leader on active surveillance for prostate cancer. Dr. Epstein serves on the National Comprehensive Cancer Network (NCCN) Prostate Cancer Early Detection Panel. Also, he is the author of the widely-cited Epstein criteria for active surveillance of prostate cancer. In addition, he serves on the Executive Council of the International Society of Urologic Pathology and is the chair of the Development Committee for the United States Canadian Division of the International Academy of Pathology. Moreover, Dr. Epstein is a recipient of the International Society of Urologic Pathology Grawitz Medal.
oncology-analytics-jay-harrisJay Harris, MD
Advisory Board Member
Dr. Harris is a professor of Radiation Oncology at Harvard Medical School. He is a highly-respected, international expert on breast cancer. His initial interest in breast cancer research was triggered because his maternal grandmother was diagnosed with the disease. Dr. Harris received his MD from Stanford University in 1970, where he also received an MS in statistics. He trained in radiation oncology at the Harvard Joint Center for Radiation Therapy, and joined the Dana-Farber Cancer Institute (DFCI) staff in 1977.
From 1985 to 1988, he was on the Editorial Board of JCO, and he served on the ASCO Board of Directors from 1997 to 2000. He also served as President and Chairman of the Board for the American Society for Therapeutic Radiology and Oncology and as a Trustee for the American Board of Radiology. From 1997 to 2015, Dr. Harris chaired the Department of Radiation Oncology at DFCI. In particular, he has been involved in the development and optimization of breast-conserving therapy for patients with invasive breast cancer and ductal carcinoma in situ. He has written over 240 peer-reviewed articles on breast malignancies. Also, he is a recipient of the 2007 ASTRO Gold Medal and the 2008 ASCO Gianni Bonadonna Breast Cancer Research Award.